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• While salivary secretion is not initiated by circulat 
ing hormones, there are significant endocrine influences on 
the development, structure and function of salivary glands. 
Experimental animal models of diabetes mellitus have been 
used to study all aspects of diabetic pathophysiolog)!. There is 
now a considerable body of evidence demonstrating that the 
effects of diabetes on rodent salivary glands are related as 
much to the indirect consequences of insulin insufficiency on 
the circulating levels of other hormones, and autonomic nerve 
function, as to the direct actions of insulin. In addition to their 
exocrine functions, salivary glands also play an endocrine 
role. Rodent submandibular glands, in particular, are a rich 
source of biologically active polypeptides, which are synthe 
sized in the granular ducts. Although many of these polypep 
tides are released into both the blood and the saliva, their 
physiological functions have yet to be fully explored. Never 
theless, the disruption of submandibular gland endocrine 
function has been postulated to contribute to the pathology 
observed in diabetic animals. (BiomedRev 1998; 9: 107-119) 
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• The function of most glands in the digestive tract is 
dependent, at least in part, on hormonal stimulation, but salivary 
gland function has been regarded as primarily, if not exclusively, 
under the control of autonomic nerves. Nonetheless, while 
salivary secretion is not initiated by circulating hormones, there 
are significant endocrine influences on the development, struc 
ture and function of salivary glands. Moreover, salivary glands 
have been postulated to have endocrine functions of their own. 
Rodent submandibular glands (SMG), in particular, synthesize 
and release into the blood a variety of biologically active po 
lypeptides for purposes that remain to be fully elucidated. 
• Diabetes mellitus 
The term diabetes mellitus refers to a group of heterogeneous 
disorders that share the common feature of glucose intolerance, 
and the key defect that leads to the onset of insulin-
dependent diabetes mellitus (IDDM, type I) is an autoimmune 
destruction of (3 cells in the pancreas and, as a consequence, a 
loss of insulin producing capacity. In contrast, non-insulin-
dependent diabetes mellitus (N1DDM, type II), which occurs 
most commonly in adults, is characterized by a derangement of 
insulin secretion and the development of insulin resistance. 
The binding of insulin to its receptor rapidly directs metabolism 
toward anabolic and away from catabolic pathways, thereby 
promoting glucose transport and carbohydrate metabolism, 




and mRNA synthesis. Experimental animal models of human 
diabetes mellitus have been used to study all aspects of diabetic 
pathobiology, but the specific effects of diabetes in any given 
tissue, including the salivary glands, are related as much to the 
indirect consequences of insulin insufficiency on blood 
chemistry, circulating levels of other hormones, and autonomic 
nerve function, as to the direct actions of insulin. 
• Animal models of diabetes mellitus 
The diabetogenic effects of alloxan were first reported in 1943 
by Dunn and colleagues, and its cytotoxic effects result from 
the intracellular generation of reactive compounds such as su-
peroxide anion and hydroxyl radicals (1). At least in the rat, 
alloxan also displays a significant degree of extrapancreatic, 
hepatic and renal, toxicity, and because of this streptozotocin has 
largely replaced alloxan as the diabetogenic agent of choice for 
this species (2). Both alloxan- and streptozotocin-diabetic 
animals exhibit polydypsia, polyuria and glycosuria, but 
unlike human diabetes mellitus the hyperglycaemia is seldom 
accompanied by ketoacidosis. As a result, alloxan- and 
streptozotocin-treated animals can usually be maintained in a 
stable diabetic state indefinitely. A spontaneous animal model 
of IDDM. the BioBreeding (BB) Laboratories Wistar rat, has 
also been used to study the dynamic physiological changes that 
occur in diabetes (3). These animals develop a syndrome that 
closely resembles the human form of the disease, both in time of 
onset and severity. Other spontaneous models of diabetes 
include the genetically diabetic (db/db) and the non-obese 
diabetic (NOD) mice. The db/db (C57BL/KsJdb) mouse is a 
model ofNIDDM, and hyperglycaemia prevails in company with 
normal or sometimes even elevated circulating levels of insulin 
(4). The NOD mouse, on the other hand, appears to be more 
suitable for the study of autoimmune salivary gland diseases, 
such as Sj ugren's syndrome (5). 
SALIVARY GLAND STRUCTURE AND EXOCRINE 
FUNCTION ll\l DIABETES MELLITUS 
• The gross morphological effects of diabetes on the 
salivary glands have been well documented. Initial reports 
demonstrated that the induction of alloxan diabetes led to a 
reduction in parotid gland and SMG weights (6,7). Virtually all 
subsequent studies confirmed these findings (8-21), and with 
only minor exceptions the SMG was more susceptible than the 
parotid gland. Insulin treatment reversed the effects of diabetes, 
and thus diabetes and insulin are generally considered to have 
parallel effects on salivary gland and body growth. The notable 
exception was the rat sublingual gland, which was relatively 
unaffected (14,20). Liu and Lin (6,7) quickly realized, however, 
that the effects of diabetes on SMG growth were not due to in 
sulin insufficiency alone. The combination of insulinand growth 
hormone, for example, was more effective than either hormone 
alone in reversing the effects of diabetes on the rat SMG. 
Moreover, diabetes resulted in a decrease in the weights of 
several endocrine glands, including the thyroid, the adrenal and 
the pituitary, suggesting that the effects of diabetes on salivary 
glands might be mediated indirectly through a decrease in the 
circulating levels of hormones other than insulin. 
• Parotidandsubmandibularacinarcellstructureand 
function 
Early morphological studies indicated that parotid and SMG 
acinar cell size was reduced in alloxan-diabetic rats (6). Later 
studies were unable to confirm such changes in short-term, 3-12 
weeks duration, streptozotocin-diabetes, but a reduction in SMG 
acinar cell size was observed in long-term, 4-6 months, 
streptozotocin-diabetic rats (17). Electron microscopy revealed a 
variety of pathological changes, including a pooling of secretory 
material and an increase in the number of autophagic vacuo-les in 
the rat SMG (17), and the presence of membrane bound 
cytoplasmic "crystalloids", which appeared to be lysosomal in 
nature, in the parotid gland (8,1 8). However, the most striking 
morphological abnormality found was the accumulation of lipid 
droplets in the basal regions of serous acinar cells (Fig. 1,2). The 
appearance of lipid in the parenchymal cells was rapid, beginning 
within 24 hours after the induction of diabetes, and it persisted 
indefinitely in the absence of insulin treatment. Little or no lipid 
was observed in the mucous acinar cells of the sublingual glands, 
and except in a few intercalated ducts, none was found in ductal 
cells. While lipid droplets were observed in all three major 
salivary glands of the rat, its accumulation in the parotid gland 
was particularly impressive (Fig. 2). On average, 8-10 % of the 
acinar cell volume was occupied by lipid, but in some instances 
the lipid displaced most of the intracellular organelles, causing 
the acinar cells to superficially resemble adipocytes. In frozen 
sections, the lipid stained with Oil Red O and calcium li-pase 
suggesting that it was comprised of neutral lipids, primarily 
triglycerides (21). Although the increased lipid could not be 
attributed to any one class, there were changes in fatty acid 
composition; C18:0 (stearic acid) and C: 18:2co6 (linoleic acid) 
increased while C18:1 co9 (oleic acid) and C20:4co6 (arachidonic 
acid) decreased (22). Why the acinar cells should accumulate 
lipid in diabetes is unknown, but three possible explanations 
present themselves: (/) the lipid may serve as a potential source 
of energy in the absence of glucose transport as it does in 
cardiac and skeletal muscle (23,24), (/'/) lipid accumulation may 
occur consequent to nonspecific endocytosis of excess 
circulating lipid (25); serum triglyceride levels are elevated in 
diabetic rats (18), and (///') lipid storage might be enhanced due 
to a decrease in its utilization for the packaging of secretory 
proteins. Insulin appears to directly stimulate acinar cell 
secretory protein synthesis in both the parotid and SMG. Parotid 
amylase levels were reduced in diabetes and insulin rapidly 











Figure 1. Electron micrograph of the submcmdibiilar gland from a control rat. The acinar cells are relatively uniform in size, and 
packed with electron-lucent secretorv granules (A). Electron micrograph of the submandibular gland from 3-week streptozotocin-
diabetic rat. Lipid droplets (L) are present in the acinar cells, but not in intercalated duct cells. Note the small serous-like 
granules in the cells of the acinar-intercalated duct interface (arrow) ( B ) .  x 4 400 (A), x 2 090 (B).From Ref 13. 
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Figure 2. Electron micrograph of the parotid gland from a control rat. The acinar cells are relatively uniform in size, and are 
packed with electron-dense secretory granules (A). Electron micrograph of the parotid gland from a 3-week slreptoiolocin-
diabetic rat (B). Lipid droplets of vary ing si:e are present in the basal portions of the acinar cells, x 3 500 (A, B). From Ref69. 




activity of acinar cell-derived peroxidase in the SMG was 
decreased in diabetic rats (13). Insulin treatment in vivo led to an 
increase in peroxidase activity and a stimulation of amino acid 
incorporation into proteins. In vitro studies confirmed that 
insulin rapidly stimulates protein synthesis in the rat SMG (26). 
The effects of insulin, however, were more specific than a 
general upregulation of protein synthesis as not all  secretory 
proteins were equally affected by diabetes and insulin (8). 
Insulin also stimulated the incorporation of glucose into SMG 
and sublingual gland glycoproteins. The depression of glucose 
incorporation was correlated with a decrease in the activities of 
several enzymes involved in the biosynthesis of hexosamines 
and sialic acid (12,27-30). Conversely, an enzyme involved in the 
degradation of glycoproteins and glycosaminoglycans, N-ace-
tyI-(3-D-glucosaminidase, was increased in streptozotocin-dia-
betes, and its activity was depressed by insulin (3 1). Differences 
in carbohydrate metabolism were also revealed histoche-
mically using glycoconjugate staining (20). 
D Granular duct structure and gene expression 
Rodent SMG are characterized by a highly specialized portion of 
the ductal system, the granular convoluted ducts (Fig. 3), 
whose secretory cells synthesize a variety of biologically active 
polypeptides, including nerve growth factor (NGF), renin and 
erythropoietin in the mouse, and epithelial growth factor (EGF) 
and kallikreins in the mouse and rat (32,33). While the 
physiological functions of many granular duct-derived peptides 
have yet to be explored fully, the granular ducts themselves are 
an excellent system to study hormonal regulation of gene 
expression. The effects of diabetes on the granular ducts were 
first noted by Parhon et a! (34), and then independently by Liu 
and Lin (6,7). Granular duct diameters were reduced in alloxan 
diabetic rats, and a similar decrease in granular duct size was 
observed in male db/dbmice (35). In female db/db mice the granular 
ducts actually became more prominent. As the effects of diabetes on 
granular duct structure were generally ascribed to an impairment of 
the hypothalamic-pituitary axis (see below), masculini-zation of 
the SMG in female db/db mice was thought to result from the 
effects of adrenal androgens, or from a defect in the 
conversion of ovarian androgens to estradiol. Despite the 
reduction in size, the overall granular duct cell morphology at the 
electron microscopical level (Fig. 3 B) was relatively unaffected in 
diabetic animals (17,18). Diabetes also had a profound effect on 
the protein synthesis by mouse granular duct cells; the levels of EG 
F and NG F decreased by greater than 50% in streptozotocin-diabetic 
and db/db mice (36-38). Protease activities, including those of 
glandular kallikrein and tonin in diabetic rats (Fig. 4) and renin 
in mice, were also decreased (16,32,39-41). Insulin treatment led to a 
complete recovery ofNGF, EGF and tissue kallikrein content in the 
mouse SMG. However, unlike acinar cell secretory proteins, the 
recovery of protein levels in the granular ducts required one week 
or more of insulin treatment. In the ca- 
se of some kallikrein-like proteases and tonin in the rat SMG, 
insulin appeared to have little, if any, effect over this time course. 
The induction of diabetes causes a reduction in the plasma 
concentrations of testosterone, thyroxine and growth hormone 
(42-44), and the recovery of normal plasma levels of these 
hormones occurs only with extended insulin treatment. Taken 
together these data support the hypothesis that the 
maintenance of granular duct gene expression is not directly 
dependent on insulin, and a brief review of the multihormonal 
regulation of granular duct structure and function is therefore 
warranted. 
• Multihormonal influences on granular duct gene 
expression 
Differences in granular duct structure between males and females 
have been described for a number of different species (32). The 
initial observations of a sexual dimorphism in the mouse SMG 
were reported independently by Lacassagne (45) and Fe-kete (46). 
The granular ducts were more prominent in male mice than in 
females, and this difference was dependent on the presence of 
androgen. However, androgens were not the only endocrine 
influences on the granular ducts by demonstrating that in male 
mice hypophysectomy had a greater effect than did castration 
(47). These results were made clear when it was shown that the 
development and maintenance of the granular ducts is 
dependent on the interaction of sexual, thyroid and adreno-
corticoid hormones (48). Over the next three decades, a variety 
of experimental approaches confirmed and extended these 
findings, and the reader is encouraged to see the reviews 
published (32,49). 
Studies conducted in the late 1940's by Junqueira et a! (50)  and 
later by Sreebny and Meyer (51) correlated the differences in 
granular duct histology and cytochemistry with the levels of 
protease activity in glandular extracts. Protease activity in 
female mice was significantly less than that in males, and in 
prepubertal mice enzymatic activity was very low and did not 
differ between males and females. In addition, protease content 
decreased in male SMG following castration, and increased in 
normal female and castrated male mice upon the administration of 
testosterone. These early studies established that androgens 
influence the levels of protease activity in the mouse SMG. 
Numerous studies have since demonstrated the effects of 
pituitary-dependent hormones on SMG proteases (32,52,53). 
The sexual dichotomy between male and female rats is far less 
than that seen in the mouse. Not all proteases are equally 
affected under all conditions, but it is clear that protease gene 
expression in rodent SMG is regulated by a complex set of 
hormonal interactions. Receptors for androgens, estrogens, 
progesterone, thyroxine and glucocorticoids have been 
demonstrated in SMG (32), and while these hormones act 
predominantly at the level of mRNA transcription, they may also 
induce changes in translational efficiency. Additional!}', 
hormonal re-   
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Figure 3. Electron micrograph of the sitbmandibiilar gland from a control rat. This represents a portion of a granular duct, 
consisting of columnar cells and containing variable numbers of secretory granules of varying electron density (A). Electron 
micrograph of the submandibiilar gland from a 3-week streptozotocin-diabetic rat. Although the morphology- of the duel cells 
appears to be relatively normal, the number of secretory granules seems to be less than in the control gland. A portion of an 
acinar cell (star) can also be seen (B). x 4 260 (A), x 4 460 (B). From Ref 13. 
 





Figure 4. Light micrograph oj the submandibulai- gland from a control rat (A). Sections stained nvV/7 D-l'al-Leu-Arg-MNA and 
Fast Blue B to demonstrate protease activity in the secretory granules of the granular ducts (asterisks). Note the intense reaction 
of the substrate over the granular ducts. Light micrograph of the submandibular gland from 3-month streptozotocin-diabetic rat 
(B). The diabetic gland shows a considerable reduction in substrate reactivity and in the number and size of the granular ducts 
(asterisks) compared with the control gland, x 200 (A, B). From Ref 13. 
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gulation of SMG mRNA expression is quite tissue specific. For 
example, renin expression in the mouse SMG was enhanced by 
testosterone and diminished by castration, whereas in the kid-
neythe reverse was observed (54,55). Thyroxine also upregula-ted 
the expression of renin mRNA inthe mouse SMG (56,57), and the 
expression of kallikrein gene family members inthe rat SMG was 
androgen and thyroid-hormone dependent as well (58,59). EGF 
and NGF expression in the mouse showed similar patterns of 
regulation by pituitary-dependent hormones (32). Each was 
present in greater concentrations in male than in female SMG. 
and castration and testosterone had opposing effects. Thyroxine 
and corticosteroids markedly increased the synthesis of EGF 
and NGF, but unlike the effects of testosterone, thyroid 
hormones preferential ly affected NGF expression (60). In general, 
the levels of mRNAEGF and mRNANGF paral leled those of the 
polypeptides themselves, and hormonal control was tissue 
specific (61 -63). Finally, estrogens antagonized the effects of 
testosterone on EGF and protease synthesis (64,65). 
• Neural regulation of parotid andsubmanclibular 
gland function in diabetes 
Because salivary gland exocrine function is almost entirely 
dependent on autonomic nerves, the question has naturally 
arisen as to whether salivary gland function in diabetes might be 
affected by alterations in the neural regulation of salivary 
secretion. Abnormalities in acinar or granular duct sensitivity to 
neurotransmitters, or the development of an autonomic nerve 
dysfunction per se would be expected to have profound effects on 
salivary gland physiology. Neuropathy is a common complication 
of diabetes, encompassing a number of clinical syndromes 
(66), and autonomic neuropathies, in particular, result in a variety 
of problems affecting the digestive, respiratory, urinary and 
reproductive systems. Chronic hyperglycaemia, which leads to 
the activation of the polyol pathway, the promotion of sorbitol 
and fructose accumulation, /Myo-inositol depletion and a slowing 
of nerve conduction velocity, appears to be a key factor in the 
development of diabetic neurpopathies. However, othermetabolic 
abnormalities, including protein glycation, su-peroxideradical 
formation, and altered amino acid and lipid metabolism, have been 
implicated. 
In the parotid gland, sympathetic and parasympathetic nerve-
stimulated salivary flow rates were reduced when compared 
with age-matched control animals (67). Parasympathetic impulses 
evoke salivary secretion largely through the activation of cho-
linergic receptors, and the impaired response could have reflected 
a decrease in the sensitivity of the acinar cells to acetylcho-line. 
However, no differences in the threshold doses formetha-choline 
orphysalaemin (a tachykinin analogue) were observed, and the 
volume of saliva secreted in response to each of these agonists 
was unaffected (68). It would appear, therefore, that the cellular 
mechanisms responsible for fluid secretion in the dia- 
betic parotid gland are intact, and that parasympathetic nerve 
dysfunction perse was responsible for the decrease in flow rate. 
Morphological evidence supported this hypothesis. Electron 
microscopy revealed a number of axonal abnormalities in the 
diabetic parotid gland (67). The interpretation of results obtained 
using continuous sympathetic stimulation in long-term diabetic 
rats was more problematical, but we have hypothesized that an 
exaggerated vasoconstriction, resulting in a dramatic 
reduction in parotid gland blood flow, was the cause of the 
diminished sympathetic response. 
The secretion of amylase from diabetic parotid glands was also 
reduced in response to direct nerve stimulation of the sympathetic 
trunk, and the reduction in amylase secretion was correlated with 
a decrease in the extent of degranulation of the acinar cells (69). 
Together with data from pharmacological and reflex secretion 
studies (70,71), these results suggested that diabetes leads 
either to a decrease in acinar cell responsiveness to P-
adrenoceptor stimulation, or to a decrease in the release of neu-
rotransmitter from sympathetic nerve terminals. Despite initial 
reports to the contrary (14) and in distinct contrast to the parotid 
gland, recent studies have shown that direct sympathetic and 
parasympathetic nerve stimulation evokes normal secretory 
responses in the SMG (19). As in the parotid gland, therefore, 
neither the morphological nor hematological abnormalities 
present in diabetic animals appear to alter submandibular fluid 
secretion. However, long-term diabetes (6 months) did lead to a 
reduction in sympathetically-stimulated protein output and 
secretory granule release. Thus, the effects of diabetes on protein 
release and fluid mobilization would appear to be independent of 
one another. 
The decrease in SMG protein output was probably due to 
several factors. First, the SMG contains two different secretory 
compartments, the acinar cells and the granular duct cells. 
Neither acinar cell size nor the relative volume density of acinar 
secretory granules were affected, but the granular duct 
compartment was significantly smaller in diabetic rats. In 
addition, there was a reduction in the volume density of 
secretory granules within the granular duct cells. Finally, 
sympathetic stimulation caused a smaller degranulation of both 
the acinar and granular duct cells in diabetic rats. This last 
observation was particularly intriguing. Sympathetic stimulation 
of acinar cells leads to a (3-adrenoceptor-mediated increase in 
cAMP, and subsequently to the exocytosis of secretory 
granules, whereas the secretion of polypeptides from the 
granular ducts is predominantly an a-adrenoceptor-mediated, Ca2' 
-dependent event. Nonetheless, the similar effects of diabetes on 
these two different intracellular signaling pathways indicate 
that some common mechanism may be involved. One possibility 
is that sympathetic nerve function was impaired in diabetic 
animals. No morphological evidence ofneuropathic changes in 
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transferase and acetylcholinesterase are altered in both diabetic 
mice and rats (72-74). However, since flow rates during 
sympathetic stimulation were unaffected, it seems reasonable 
to infer that nerve impulse formation and neurotransmitter release 
were normal. This same conclusion pertains to the parotid gland. In 
addition, changes in acetylcholinesterase histochemistry and 
catecholamine fluorescence in db/db mice were found, and the 
differences were largely due to the effects of diabetes on the 
granular ducts, and a corresponding diminished neurotrophic 
effect of NGF (35,75). A second possibility is that the effects of 
diabetes on protein secretion were due to a change in adreno-
ceptor density or sensitivity. Thyroid hormones, for example, 
modulate SMG responses to a variety of neurotransmitters and 
neuropeptides (76-78), and circulating levels ofthyroid hormones 
are reduced in diabetic animals. The third possibility is that the 
changes in membrane fatty acid profiles might alter both 
cAMP metabolism, as well as the generation of intracellular 
signaling molecules such as inositol trisphosphate and diacyl-
glycerol, from membrane phospholipids (79). Determining which, if 
any, of these hypotheses is correct awaits further investigation. 
SUBMANDIBULAR GLAND ENDOCRINE FUNCTIONS IN 
DIABETES MELLITUS 
• The exocrine function of the SMG has been studied 
extensively, but the precise physiological roles played by the 
polypeptides synthesized in the granular ducts remain to be 
fully explored. Numerous studies have shown that the circulat 
ing serum levels of many of these biologically active substan 
ces are derived in part from the SMG, and thus the salivary 
glands have been hypothesized to have an endocrine function 
and to participate in regulating a variety of physiological pro 
cesses, including reproductive tract function, neuroimmune 
responses and glucose homeostasis (80-83). 
• Submandibular gland as an endocrine organ 
Classically, endocrine cells and organs are characterized by 
their ability to sense changes in the internal environment, and as 
a consequence modulate the release of biologically active 
substances into the bloodstream. Under normal physiological 
conditions, endocrine cell function is regulated via both positive 
and negative feedback loops, thereby maintaining a relatively 
stable metabolic state. Such mechanisms have been 
classically termed homeostatic (83). With respect to salivary 
glands, responses to specific alterations in the levels of 
metabolites or other circulating substances remain speculative. 
Nonetheless, there appears to be a release of kallikreins, EGF, 
NGF and renin from SMG into the blood (84-86) under both 
resting and stimulated conditions, and experiments involving 
salivary gland ablation suggest that this constitutive release of 
biologically active polypeptides from the SMG contributes 
signifi- 
cantly to the regulation and maintenance of homeostasis (79-
83). SMG-deri ved EGF, for example, is thought to be necessary 
for normal liverregeneration after partial hepatectomy (87) and 
for male reproductive function (88), whereas sialoadenectomy 
increases the response to endotoxin (89). 
• Submandibular gland endocrine dysfunction and 
diabetic pathophysiology 
In contrast to homeostatic mechanisms, allostatic processes, 
which may be entirely inappropriate for normal function, 
become operative under pathological conditions (83). Under this 
allostatic model, changes in the exocrine or endocrine 
functions of salivary glands could contribute to the 
pathology associated with the onset of diabetes mellitus. The 
deficiencies in Submandibular EGF and NGF content were 
correlated with reductions in the plasma levels of these 
polypeptides, and the lower circulating levels of EFG andNGF 
have been hypothesized to play a role in the development of 
oligozoospermia (36) and diabetic neuropathy (37,3 8), 
respectively. SMG-derived NGF and EGF have also been 
proposed to contribute to systemic immu-noregulation and 
neuroendocrine function, and one could speculate that diabetic 
complications, such as poor wound healing, may be due in part 
to a disruption in this neuroimmunore-gulatory network (82). 
Alternatively, the effects of salivary constituents, which are 
inconsequential under normal circumstances, may be 
manifested in the disease state. No role for SMG-derived 
immunoreactive glucagon has been documented in carbohydrate 
homeostasis (83,90). However, salivary gland hyperglycemic 
factors, such as glucagon, have been suggested to exacerbate the 
increase in blood glucose observed in both IDDM andNlDDM 
animal models (91,92). Chronic hyperglyce-mia has been 
hypothesized to be a major factor in the development of vascular 
and neural complications in diabetes (66,93), and the 
inappropriate maintenance of increased serum glucose levels by 
extrapancreatic glucagon would therefore represent an allostatic 
load (83) contributing to the morbidity observed in diabetes 
mellitus. 
CONCLUSION 
• Saliva plays an important role in the protection of the 
oral cavity, and alterations in either salivary flow rate or compo 
sition are known to have dramatic effects on oral health. There 
is, however, a considerable divergence of opinion in the litera 
ture as to the extent, or even the existence, of changes in salivary 
composition and flow rate in insulin-treated, human diabetic 
patients. Nonetheless, over the past 40 years it has become clear 
that insulin and insulin insufficiency have both direct and 
indirect effects on the structure and function of the salivary 
glands. Insulin appears to play a direct role in the regulation of 
gene expression in the acinar cells, whereas its role in modulat-   
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ing gene expression in the granular ducts of the rodent SMG is 
likely to be an indirect one, mediated via the effects of diabetes on 
pituitary-dependent hormones. Diabetes may also influence 
salivary gland function through altered autonomic nerve func-
tionperse. Finally, the investigation of salivary gland structure 
and function in experimental diabetes has provided fundamental 
insights into the physiology of the salivary glands. Salivary 
glands, in turn, may be a valuable model system in which to 
study the development and pathophysiology of diabetes. 
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